HKU Scholars Hub: Browsing DSpace

Browsing by Author Gupta, SV

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 9 of 9

	Title	Author(s)	Issue Date
	A phase 1 study evaluating the neutralizing, vaccinal monoclonal antibody VIR-3434 in participants with chronic hepatitis B virus infection Proceeding/Conference:Journal of Hepatology	Agarwal, K Yuen, RMF Wedemeyer, H Cloutier, D Shen, L Arizpe, A Pang, P Tay, C Gupta, SV Cathcart, A Gane, E	2021
	Dose-dependent durability of hepatitis B surface antigen reductions following administration of a single dose of VIR-3434, a novel neutralizing vaccinal monoclonal antibody. Poster Presentation (SAT837) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Agarwal, A Yuen, RMF Wedemeyer, H Cloutier, D Shen, L Arizpe, A Gupta, SV Fanget, MC Seu, J Cathcart, A Lau, AH Hwang, C Gane, EJ	2022
	Hepatitis B surface antigen (HBsAg) reductions following administration of a single dose of VIR-3434, an investigational, neutralizing, vaccinal monoclonal antibody: first experience in participants with high HBsAg burden Proceeding/Conference:Hepatology International	Yuen, MF Agarwal, K Wedemeyer, H Cloutier, D Shen, L Arizpe, A Hassani, A Gupta, SV Hwang, C Gane, E Agarwal, K	31-Mar-2023
	Longer treatment duration of monthly VIR-2218 results in deeper and more sustained reductions in hepatitis B surface antigen in participants with chronic hepatitis B infection. Oral Presentation (OS090) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Lim, YS Yuen, RMF Cloutier, D Thanawala, V Shen, L Gupta, SV Arizpe, A Cathcart, A Hwang, C Gane, EJ	2022
	Preliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Yuen, RMF Lim, YS Cloutier, D Shen, L Arizpe, A Pang, P Tay, C Thanawala, V Gupta, SV Cathcart, A Gane, E	2021
	Preliminary results from a phase 2 study evaluating vir-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Oral Presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Yuen, RMF Lim, Y-S Cloutier, D Thanawala, V Shen, L Arizpe, A Tay, C Gupta, SV Cathcart, AL Hwang, C Pang, PS Gane, EJ	2021
	Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Yuen, RMF Lim, Y-S Cloutier, D Thanawala, V Shen, L Arizpe, A Tay, C Gupta, SV Cathcart, AL Hwang, C Gane, E	2022
	Rapid HBsAg reduction in chronic hepatitis B virus infection: preliminary results from a phase 1 study evaluating a single dose of VIR-3434, a novel neutralizing, vaccinal monoclonal antibody Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Agarwal, K Yuen, RMF Wedemeyer, H Arizpe, A Shen, L Cloutier, D Tay, C Gupta, SV Fanget, MC Dholakiya, SL Seu, L Cathcart, AL Hwang, C Pang, PS Gane, EJ	2021
	Reduction in Hepatitis B Viral DNA and Hepatitis B Surface Antigen Following Administration of a Single Dose of VIR-3434, an Investigational Neutralizing Monoclonal Antibody: First Experience in a Population With Viremia Proceeding/Conference:The Liver Meeting 2022: American Association for the Study of Liver Diseases (AASLD) (04/11/2022-08/11/2022, Washington, USA)	Agarwal, K Yuen, MF Wedemeyer, H Cloutier, D Shen, L Arizpe, A Gupta, SV Fanget, M Seu, L Cathcart, AL Lau, AH Hwang, C Gane, E	31-Oct-2022

Showing results 1 to 9 of 9